VTX-2337
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for VTX-2337, covering 2014-10-06 to 2019-10-29. Get the full timeline:
Most recent: Clinical Trial Update: Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]